Global Codeine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Codeine market size will reach 253.10 Million USD in 2025 and is projected to reach 168.58 Million USD by 2032, with a CAGR of -5.64% (2025-2032). Notably, the China Codeine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Codeine is a prescription medication classified as an opioid analgesic, used primarily for pain relief and cough suppression. It is derived from the opium poppy and belongs to the same drug class as morphine and hydrocodone. Codeine works by binding to opioid receptors in the brain and spinal cord, which reduces the perception of pain and can also cause a sense of euphoria. Due to its potential for abuse and addiction, codeine is typically prescribed for short-term use and under strict medical supervision. In addition to pain relief, codeine can be found in some over-the-counter cough and cold medications to suppress coughing. However, its use should be carefully monitored, especially in combination with other medications or alcohol, as it can lead to serious side effects or interactions. Common side effects of codeine include drowsiness, constipation, and nausea. Because of its addictive potential, it is essential for individuals to follow their healthcare provider's instructions and avoid misuse or prolonged use of codeine.
The major global suppliers of Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Aristo Pharma GmbH, Mylan, Lannett Company, Laboratoire Riva, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Codeine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Codeine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Codeine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Codeine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Codeine Include:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Aristo Pharma GmbH
Mylan
Lannett Company
Laboratoire Riva
Codeine Product Segment Include:
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Product Application Include:
Narcotic Analgesic
Antitussive
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Codeine Industry PESTEL Analysis
Chapter 3: Global Codeine Industry Porter's Five Forces Analysis
Chapter 4: Global Codeine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Codeine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Codeine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Codeine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Codeine market size will reach 253.10 Million USD in 2025 and is projected to reach 168.58 Million USD by 2032, with a CAGR of -5.64% (2025-2032). Notably, the China Codeine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Codeine is a prescription medication classified as an opioid analgesic, used primarily for pain relief and cough suppression. It is derived from the opium poppy and belongs to the same drug class as morphine and hydrocodone. Codeine works by binding to opioid receptors in the brain and spinal cord, which reduces the perception of pain and can also cause a sense of euphoria. Due to its potential for abuse and addiction, codeine is typically prescribed for short-term use and under strict medical supervision. In addition to pain relief, codeine can be found in some over-the-counter cough and cold medications to suppress coughing. However, its use should be carefully monitored, especially in combination with other medications or alcohol, as it can lead to serious side effects or interactions. Common side effects of codeine include drowsiness, constipation, and nausea. Because of its addictive potential, it is essential for individuals to follow their healthcare provider's instructions and avoid misuse or prolonged use of codeine.
The major global suppliers of Codeine include Taiji, Mallinckrodt, TEVA, Johnson & Johnson, Medreich, Sanofi Aventis, Cipla, Hikma, Pharmaceutical Associates, Novartis, Apotex, Aristo Pharma GmbH, Mylan, Lannett Company, Laboratoire Riva, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Codeine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Codeine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Codeine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Codeine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Codeine Include:
Taiji
Mallinckrodt
TEVA
Johnson & Johnson
Medreich
Sanofi Aventis
Cipla
Hikma
Pharmaceutical Associates
Novartis
Apotex
Aristo Pharma GmbH
Mylan
Lannett Company
Laboratoire Riva
Codeine Product Segment Include:
Single-ingredient Codeine
Multi-ingredient Medications
Codeine Product Application Include:
Narcotic Analgesic
Antitussive
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Codeine Industry PESTEL Analysis
Chapter 3: Global Codeine Industry Porter's Five Forces Analysis
Chapter 4: Global Codeine Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Codeine Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Codeine Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Codeine Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Codeine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Codeine Product by Type
- 1.2.1 Single-ingredient Codeine
- 1.2.2 Multi-ingredient Medications
- 1.3 Codeine Product by Application
- 1.3.1 Narcotic Analgesic
- 1.3.2 Antitussive
- 1.3.3 Others
- 1.4 Global Codeine Market Size Analysis (2020-2032)
- 1.5 Codeine Market Development Status and Trends
- 1.5.1 Codeine Industry Development Status Analysis
- 1.5.2 Codeine Industry Development Trends Analysis
- 2 Codeine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Codeine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Codeine Market Analysis by Country
- 4.1 Global Codeine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Codeine Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Codeine Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Codeine Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Codeine Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Codeine Market Revenue and Growth Rate (2020-2032)
- 4.5 China Codeine Market Revenue and Growth Rate (2020-2032)
- 4.6 France Codeine Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Codeine Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Codeine Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Codeine Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Codeine Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Codeine Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Codeine Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Codeine Market Revenue and Growth Rate (2020-2032)
- 4.14 India Codeine Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Codeine Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Codeine Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Codeine Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Codeine Market Revenue by Key Suppliers (2021-2025)
- 5.2 Codeine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Codeine Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Codeine Market Analysis by Type
- 6.1 Global Codeine Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Codeine Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Taiji
- 7.1.1 Taiji Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Taiji Codeine Product Portfolio
- 7.1.3 Taiji Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Mallinckrodt
- 7.2.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Mallinckrodt Codeine Product Portfolio
- 7.2.3 Mallinckrodt Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 TEVA
- 7.3.1 TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 TEVA Codeine Product Portfolio
- 7.3.3 TEVA Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 Johnson & Johnson
- 7.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Johnson & Johnson Codeine Product Portfolio
- 7.4.3 Johnson & Johnson Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Medreich
- 7.5.1 Medreich Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Medreich Codeine Product Portfolio
- 7.5.3 Medreich Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sanofi Aventis
- 7.6.1 Sanofi Aventis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sanofi Aventis Codeine Product Portfolio
- 7.6.3 Sanofi Aventis Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Cipla
- 7.7.1 Cipla Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Cipla Codeine Product Portfolio
- 7.7.3 Cipla Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Hikma
- 7.8.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Hikma Codeine Product Portfolio
- 7.8.3 Hikma Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Pharmaceutical Associates
- 7.9.1 Pharmaceutical Associates Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Pharmaceutical Associates Codeine Product Portfolio
- 7.9.3 Pharmaceutical Associates Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Novartis
- 7.10.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Novartis Codeine Product Portfolio
- 7.10.3 Novartis Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Apotex
- 7.11.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Apotex Codeine Product Portfolio
- 7.11.3 Apotex Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Aristo Pharma GmbH
- 7.12.1 Aristo Pharma GmbH Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Aristo Pharma GmbH Codeine Product Portfolio
- 7.12.3 Aristo Pharma GmbH Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Mylan
- 7.13.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Mylan Codeine Product Portfolio
- 7.13.3 Mylan Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Lannett Company
- 7.14.1 Lannett Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Lannett Company Codeine Product Portfolio
- 7.14.3 Lannett Company Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Laboratoire Riva
- 7.15.1 Laboratoire Riva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Laboratoire Riva Codeine Product Portfolio
- 7.15.3 Laboratoire Riva Codeine Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Codeine Industry Chain Analysis
- 8.2 Codeine Product Downstream Application Analysis
- 8.2.1 Global Codeine Market Size and Growth Rate (CAGR) by Application: 2024 VS 2025 VS 2032
- 8.2.2 Global Codeine Revenue and Forecast by Application (2020-2032)
- 8.3 Codeine Typical Downstream Customers
- 8.4 Codeine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
